logo-loader
Motif Bio PLC

Motif Bio appoints long-standing board member Bruce Williams as interim chairman, replacing Richard C.E. Morgan

It pointed out that Williams has significant operational experience in the biopharmaceutical industry and has held senior leadership positions at both large pharmaceutical firms and start-up biotechs

Handshake
It said Morgan has agreed to remain available to the company in the coming months on an as needed basis to ensure a smooth transition

Motif Bio PLC (LON:MTFB) (NASDAQ:MTFB) has appointed long-standing board member Bruce Williams as its interim chairman to replace Richard C.E. Morgan who is stepping down with immediate effect to focus on other business commitments.

The AIM-listed group said Morgan has agreed to remain available to the company in the coming months on an as needed basis to ensure a smooth transition.

READ: Motif Bio to manage cash aggressively after making loan repayment

The company pointed out that Williams has significant operational experience in the biopharmaceutical industry and has held senior leadership positions at both large pharmaceutical firms and start-up biotechs.

It said he served as senior vice president, global business management at Enzon Pharmaceuticals, where he led the company's commercial functions, prior to that, he was senior vice president, sales & marketing at Genta Incorporated.

Graham Lumsden, Motif Bio’s chief executive officer commented: "We are delighted that Bruce has agreed to step into the interim Chairman role. He is a strong leader who has held senior executive positions, particularly in strategic product planning and commercialisation, at a number of biopharmaceutical companies.”

The CEO added: “I look forward to continuing to work with him as Motif Bio seeks to advance iclaprim towards approval. We have submitted a meeting request and package to the FDA and expect to work collaboratively with the Agency over the coming weeks."

Quick facts: Motif Bio PLC

Price: £0.02

Market: AIM
Market Cap: £8.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Motif Bio PLC named herein, including the promotion by the Company of Motif Bio PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: AfriTin Mining produces first concentrate from Uis mine

Headlines from the Proactive UK newsroom. AfriTin Mining (LON:ATM) has produced is first tin concentrate from the Uis mine in Namibia. The miner has also signed an offtake deal with a Thai group.  BlueRock Diamonds (LON:BRD) has sold a fifth diamond this year for more than US$50,000....

2 days, 17 hours ago

2 min read